USE OF AN ALGORITHM TO SPEED-UP, STREAMLINE THE FORMULARY REVIEW PROCESS

Colleagues at University Medical Center, Tucson, revised their formula ry review process with the ultimate goal of shortening the time betwee n FDA approval of a new drug and P & T Committee consideration of the product for formulary inclusion/exclusion. To streamline the formulary review process, a decision algorithm was developed. Movement toward a more proactive review process, description of the decision algorithm, and initial results associated with use of their new drug review proc ess are presented in this article.